The effect of exemestane, anastrozole, and tamoxifen on lipid profiles in Japanese postmenopausal early breast cancer patients: final results of National Surgical Adjuvant Study BC 04, the TEAM Japan sub-study
Author:
Funder
Comprehensive Support Project for Oncology Research
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/22/8/1777/19482377/mdq707.pdf
Reference21 articles.
1. Cancer burden in the year 2000. The global picture;Parkin;Eur J Cancer,2001
2. Emerging role of aromatase inhibitors in the adjuvant setting;Goss;Am J Clin Oncol,2003
3. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer;Coombes;N Engl J Med,2004
4. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer;Howell;Lancet,2005
5. Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial;Coombes;Lancet,2007
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The effect of exemestane administration on the lipid profile in women: Meta-analysis of randomized controlled trials;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-04
2. Lipid changes during endocrine therapy in early-stage breast cancer patients: A real-world study;Lipids in Health and Disease;2024-01-08
3. Diabetes mellitus in breast cancer survivors: metabolic effects of endocrine therapy;Nature Reviews Endocrinology;2023-10-02
4. Letrozole ameliorates fructose-induced hyperlipidaemia and uric acid accumulation in male Wistar rats;PHYSIOL PHARMACOL;2023
5. Letrozole ameliorates fructose-induced hyperlipidaemia and uric acid accumulation in male Wistar rats;Physiology and Pharmacology;2023-07-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3